Pluripotent cells in embryogenesis and in teratoma formation

Journal of Stem Cells

Volumn 6, Issue 1, 2011, Pages 51-63

  Gordeeva, O F ^a  

^a KOL TSOV INSTITUTE OF DEVELOPMENTAL BIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 4; FIBROBLAST GROWTH FACTOR 2; GLYCOGEN SYNTHASE KINASE 3; OCTAMER TRANSCRIPTION FACTOR 4; POLYCOMB GROUP PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXD3; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR SOX2; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL MIGRATION; CELL RENEWAL; CELL STRUCTURE; CELL VIABILITY; DEMETHYLATION; ECTODERM; EMBRYO DEVELOPMENT; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; GASTRULA; GASTRULATION; GENE EXPRESSION; GERM CELL TUMOR; HISTOGENESIS; HUMAN; LEUKEMIA; LYMPHOMA; MEDULLOBLASTOMA; MELANOMA; MORULA; NONHUMAN; PLURIPOTENT STEM CELL; PRIMORDIAL GERM CELL; PROTEIN BINDING; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; STEM CELL NICHE; STEM CELL TRANSPLANTATION; TERATOMA; TROPHOBLAST; ADULT; ANIMAL; ANIMAL EMBRYO; CYTOLOGY; MOUSE; PATHOLOGY; REVIEW;

ANIMALIA; MUS;

ADULT; ANIMALS; CELL DIFFERENTIATION; EMBRYO, MAMMALIAN; HUMANS; MICE; PLURIPOTENT STEM CELLS; TERATOMA;

EID: 84867286201     PISSN: 15568539     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (71)

1. Reya, T., Morrison, S.J., Clarke, M.F. and Weissman, I.L. (2001). Stem cells, cancer, and cancer stem cells. Nature, 414, 105-111.
2. Appelbaum, F.R., Rowe, J.M., Radich, J. and Dick, J.E. (2001). Acute myeloid leukemia. Hematology Am Soc Hematol Educ Program., 62-86.
3. Dick, J.E. (2003). Breast cancer stem cells revealed. PNAS, 100, 3547-3549.
4. Clarke, M.F. and Becker, M.W. (2006). Stem cells: The Real Culprits in Cancer? Scientific American, July, 53-59.
5. Morrison, S.J. and Kimble, J. (2006). Asymmetric and symmetric stem-cell divisions in development and cancer. Nature, 441, 1068-1074.
6. Stevens, L.C. and Little, C.C. (1954). Spontaneous testicular teratomas in an inbred strain of mice. Proc Natl Acad Sci U S A, 40, 1080-1087.
7. D'Amour K.A. and Gage F.H. (2003). Genetic and functional differences between multipotent neural and pluripotent embryonic stem cells. Proc. Natl. Acad. Sci. USA., 100 (suppl 1), 11866-11872.
8. Ramalho-Santos, M., Yoon S., Matsuzaki Y., Mulligan R.C. and Melton D.A. (2002). Stemness: transcriptional profiling of embrionic and adult stem cells. Science, 298, 597-600.
9. Tanaka, T.S., Kunath, T., Kimber, W.L., Jaradat, S.A., Stagg, C.A., Usuda, M., Yokota, T., Niwa, H., Rossant J. and Ko, M.S. (2002). Gene expression profiling of embryo-derived stem cells reveals candidate genes associated with pluripotency and lineage specificity. Genome Res, 12, 1921-1928
10. Tanaka, T.S., Jaradat, S.A., Lim, M.K., Kargul, G.J., Wang, X., Grahovac, M.J., Pantano, S., Sano, Y., Piao, Y., Nagaraja, R., Doi, H., Wood, W.H. 3rd, Becker, K.G. and Ko M.S (2000). Genome-wide expression profiling of mid-gestation placenta and embryo using a 15,000 mouse developmental cDNA microarray. Proc. Natl. Acad. Sci. US., 97(16), 9127-9132.
11. Palmieri, S.L., Peter, W., Hess, H. and Scholer, H.R. (1994). Oct-4 transcription factor is differentially expressed in the mouse embryo during establishment of the first two extraembryonic cell lineages involved in implantation. Dev. Biol., 166, 259-267.
12. Evans, M.J. and Kaufman, M.H. (1981). Establishment in culture of pluripotential cells from mouse embryos. Nature, 292, 154-156.
13. Martin, G.R. (1981). Isolation of pluripotent cell line from early mouse embryo cultured in medium conditioned by teratocarcinoma stem cells. Proc. Natl. Acad. Sci. US., 78, 7634-7638.
14. Rossant, J. (2001). Stem cells from mammalian blastocyst. Stem Cells, 19, 477-482.
15. Thomson, J.A., Itskovitz-Eldor, J., Shapiro, S.S., Waknitz, M.A., Swiergiel, J.J, Marshall, V.S. and Jones J.M. (1998). Embryonic stem cell lines derived from human blastocysts. Science, 282(5391), 1145-1147.
16. Matsui, Y., Zsebo, K., Hogan, B.L. (1992). Derivation of pluripotential embryonic stem cells from murine primordial germ cells in culture. Cell, 70, 841-847
17. Resnick, J.L., Bixler, L.S., Cheng, L and Donovan, P.J. (1992). Long-term proliferation of mouse primordial germ cells in culture. Nature, 359, 550-551
18. Bradley, A., Evans, M., Kaufman, M.H. and Robertson, E. (1984). Formation of germ-line chimaeras from embryo-derived teratocarcinoma cell lines. Nature, 309,255-256.
19. Kanatsu-Shinohara, M., Inoue, K., Lee, J., Yoshimoto, M., Ogonuki, N., Miki, H., Baba, S., Kato, T., Kazuki, Y., Toyokuni, S., Toyoshima, M., Niwa, O., Oshimura, M., Heike, T., Nakahata, T., Ishino, F., Ogura, A. and Shinohara, T.(2004). Generation of pluripotent stem cells from neonatal mouse testis. Cell, 119, 1001-1012.
20. Guan, K., Nayernia, K., Maier, L.S., Wagner, S., Dressel, R., Lee, J.H., Nolte, J., Wolf, F., Li, M., Engel, W. and Hasenfuss, G. (2006). Pluripotency of spermatogonial stem cells from adult mouse testis. Nature, 440, 1199-1203.
21. Martin, G.R. and Evans, M.J. (1975). Differentiation of clonal lines of teratocarcinoma cells: formation of embryoid bodies in vitro. Proc Natl Acad Sci US, 72, 1441-1445.
22. Andrews, P.W. (2002). From teratocarcinomas to embryonic stem cells. Philos Trans R Soc Lond B Biol Sci., 357, 405-417.
23. Mintz, B. and Illmensee, K. (1975). Normal genetically mosaic mice produced from malignant teratocarcinoma cells. Proc Natl Acad Sci U S A., 72, 3585-3589.
24. Illmensee, K. and Mintz, B. (1976). Totipotency and normal differentiation of single teratocarcinoma cells cloned by injection into blastocysts. Proc Natl Acad Sci US, 73, 549-553.
25. Stewart, T.A. and Mintz, B. (1981). Successive generations of mice produced from an established culture line of euploid teratocarcinoma cells. Proc Natl Acad Sci US, 78, 6314-6318.
26. Rossant, J. and McBurney, M.W (1982). The developmental potential of a euploid male teratocarcinoma cell line after blastocyst injection. J Embryol Exp Morphol, 70, 99-112.
27. Przyborski, S.A. (2005). Differentiation of Human Embryonic Stem Cells After Transplantation in Immune- Deficient Mice. Stem Cells, 23, 1242-1250.
28. Hochedlinger, K. and Jaenisch, R. (2006). Nuclear reprogramming and pluripotency. Nature, 441, 1061-1067
29. Blelloch, R.H., Hochedlinger, K., Yamada, Y., Brennan, C., Kim, M., Mintz, B., Chin, L. and Jaenisch, R. (2004). Nuclear cloning of embryonal carcinoma cells. Proc Natl Acad Sci US, 101, 13985-13990.
30. Hochedlinger, K., Blelloch, R., Brennan, C., Yamada, Y., Kim, M., Chin, L. and Jaenisch, R. (2004). Reprogramming of a melanoma genome by nuclear transplantation. Genes Dev., 18, 1875-1885.
31. Tada, M., Tada, T., Lefebvre, L., Barton, S.C. and Surani, M.A. (1997). Embryonic germ cells induce epigenetic reprogramming of somatic nucleus in hybrid cells. EMBO J., 16, 6510-6520.
32. Tada, M., Takahama, Y., Abe, K., Nakatsuji, N. and Tada, T. (2001). Nuclear reprogramming of somatic cells by in vitro hybridization with ES cells. Curr Biol., 11, 1553-1558.
33. Tada, M., Morizane, A., Kimura, H., Kawasaki, H., Ainscough, J.F., Sasai, Y., Nakatsuji, N. and Tada, T. (2003). Pluripotency of reprogrammed somatic genomes in embryonic stem hybrid cells. Dev Dyn., 227, 504-510.
34. Bortvin, A., Eggan, K., Skaletsky, H., Akutsu, H., Berry, D.L., Yanagimachi, R., Page, D.C. and Jaenisch, R. (2003). Incomplete reactivation of Oct4-related genes in mouse embryos cloned from somatic nuclei. Development, 130, 1673-1680.
35. Cowan, C.A, Atienza, J., Melton, D.A. and Eggan, K. Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells. Science, 309, 1369-1373.
36. Niwa, H., Miyazaki J. and Smith, A.G. (2000). Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet., 24, 372-376.
37. Boiani, M. and Schöler, H.R. (2005). Regulatory networks in embryo-derived pluripotent stem cells. Nat. Rev. Mol. Cell Biol., 6, 872-884.
38. Chambers, I., Colby, D., Robertson, M., Nichols, J., Lee, S., Tweedie, S. and Smith, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell, 113, 643-655.
39. Mitsui, K., Tokuzawa, Y., Itoh, H., Segawa, K., Murakami, M., Takahashi, K., Maruyama, M., Maeda, M. and Yamanaka, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell, 113, 631-642.
40. Hart, A.H., Hartley, L., Ibrahim, M. and Robb, L. (2004). Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn., 230, 187-198.
41. Chambers, I. and Smith, A. (2004). Self-renewal of teratocarcinoma and embryonic stem cells. Oncogene, 23, 7150-7160.
42. Boyer, L.A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L.A., Lee, T.I., Levine, S.S., Wernig, M., Tajonar, A., Ray, M.K., Bell, G.W., Otte, A.P., Vidal, M., Gifford, D.K., Young, R.A. and Jaenisch, R. (2006). Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature, 441, 349-353.
43. Lee, T.I., Jenner, R.G., Boyer, L.A., Guenthe, M.G., Levine, S.S., Kumar, R.M., Chevalier, B., Johnstone, S.E., Cole, M.F., Isono, K., Koseki, H., Fuchikami, T., Abe, K., Murray, H.L., Zucker, J.P., Yuan, B., Bell, G.W., Herbolsheimer, E., Hannett, N.M., Sun, K., Odom, D.T., Otte, A.P., Volkert, T.L., Bartel, D.P., Melton, D.A., Gifford, D.K., Jaenisch, R. and Young, R.A. (2006). Control of developmental regulators by Polycomb in human embryonic stem cells. Cell, 125, 301-313.
44. Smith, A.G., Heath, J.K., Donaldson, D.D., Wong, G.G., Moreau, J., Stahl, M. and Rogers, D. (1988). Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature, 336, 684-687.
45. Boeuf, H., Hauss, C., Graeve, F.D., Baran, N. and Kedinger, C. (1997). Leukemia inhibitory factordependent transcriptional activation in embryonic stem cells. J. Cell Biol., 138, 1207-1217.
46. Niwa, H., Burdon, T., Chambers, I. and Smith, A. (1998). Self-renewal of pluripotent embryonic stem cells is mediated via activation of STAT3. Genes Dev., 12, 2048-2060.
47. Nichols, J., Davidson, D., Taga, T., Yoshida, K., Chambers, I. and Smith, A. (1996). Complementary tissue-specific expression of LIF and LIF-receptor mRNAs in early mouse embryogenesis. Mech Dev., 57, 123-131.
48. Daheron, L., Opitz, S.L., Zaehres, H., Lensch, W.M., Andrews, P.W., Itskovitz-Eldor, J. and Daley, G.Q. (2004). LIF/STAT3 signaling fails to maintain selfrenewal of human embryonic stem cells. Stem Cells, 22, 770-778.
49. Ying, Q.L., Nichols, J., Chambers, I. and Smith, A. (2003). BMP induction of Id proteins suppresses differentiation and sustains embryonic stem cell selfrenewal in collaboration with STAT3. Cell, 115, 281-292.
50. Gerami-Naini, B., Dovzhenko, O.V., Durning, M., Wegner, F.H., Thomson, J.A. and Golos, T.G. (2004). Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology, 145, 1517-1524.
51. Schuldiner, M., Yanuka, O., Itskovitz-Eldor, J., Melton, D.A. and Benvenisty, N. (2000). Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci US, 97, 11307-11312.
52. Sato, N., Meijer, L., Skaltsounis, L., Greengard, P., Brivanlou, A.H. (2004). Maintenance of pluripotency in human and mouse embryonic stem cells through activation of Wnt signaling by a pharmacological GSK-3-specific inhibitor. Nat Med., 10, 55-63.
53. Paling, N.R., Wheadon, H., Bone, H.K. and Welham, M.J. (2004). Regulation of embryonic stem cell selfrenewal by phosphoinositide 3-kinase-dependent signaling. J. Biol. Chem., 279, 48063-48070.
54. Hao, J., Li, T.G., Qi, X., Zhao, D.F. and Zhao, G.Q. (2006). WNT/beta-catenin pathway up-regulates Stat3 and converges on LIF to prevent differentiation of mouse embryonic stem cells. Dev. Biol., 290, 81-91.
55. Beattie, G.M., Lopez, A.D., Bucay, N., Hinton, A., Firpo, M.T., King, C.C. and Hayek, A. (2005). Activin A maintains pluripotency of human embryonic stem cells in the absence of feeder layers. Stem Cells, 23, 489-495,
56. Vallier, L., Alexander, M. and Pedersen, R.A. (2005). Activin/Nodal and FGF pathways cooperate to maintain pluripotency of human embryonic stem cells. J. Cell Sci., 118, 4495-4509.
57. Krasnikova, N.Y. and Gordeeva, O.F. (2006). Nodal signaling in the regulation of pluripotent state ofhuman and mouse ES and EC cells. FEBS, 273 (suppl 1), 126.
58. Stevens, L.C. and Varnum, D.S. (1974). The development of teratomas from parthenogenetically activated ovarian mouse eggs. Dev Biol., 37, 369-380.
59. Lefebvre, R., Theoret, C., Dore, M., Girard, C., Laverty, S. and Vaillancourt, D. (2005). Ovarian teratoma and endometritis in a mare. Can. Vet J., 46, 1029-1033.
60. Carver, B.S., Bianco, F.J. Jr., Shayegan, B., Vickers, A., Motzer, R.J., Bos, G.J. and Sheinfeld, J. (2006). Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. J. Urol., 176, 100-103.
61. Aubry, F., Satie, A.P., Rioux-Leclercq, N., Rajpert-DeMeyts, E, Spagnoli, G.C., Chomez, P., De Backer, O., Jegou, B. and Samson, M. (2001). MAGE-A4, a germ cell specific marker, is expressed differentially in testicular tumors. Cancer, 92, 2778-2785.
62. Stevens, L.C. (1964). Experimental production of testicular teratomas in mice. Proc Natl Acad Sci US, 52,654-561
63. Bendel-Stenzel, M., Anderson, R., Heasman, J. and Wylie, C. (1998). The origin and migration of primordial germ cells in the mouse. Semin Cell Dev Biol., 9, 393-400.
64. Kleinsmith, L.J. and Pierce, G.B. Jr. (1964). Multipotentiality of single embryonal carcinoma cells. Cancer Res., 24, 1544-1551
65. Solter, D., Skreb, N. and Damjanov, I. (1970). Extrauterine growth of mouse egg-cylinders results in malignant teratoma. Nature, 227,503-504.
66. Stevens, L.C. (1970). The development of transplantable teratocarcinomas from intratesticular grafts of pre- and postimplantation mouse embryos. Dev Biol., 21, 364-382.
67. Gordeeva, O.F., Manuilova, E.S., Paiushina, O.V., Nikonova, T.M., Grivennikov, I.A. and Khrushchev, N.G. (2003). Differentiation of pluripotent embryonic stem cells in peritoneal cavity of irradiated mice. Izv Akad Nauk Ser Biol., 3, 371-374.
68. Gordeeva, O., Zinovieva, R., Smirnova, Y., Payushina, O., Nikonova, T. and Khrushchov, N. (2005). Differentiation of embryonic stem cells after transplantation into peritoneal cavity of irradiated mice and expression of specific germ cell genes in pluripotent cells. Transplant Proc., 37, 295-298
69. Rugg-Gunn, P.J., Ferguson-Smith, A.C. and Pedersen, R.A. (2005). Epigenetic status of human embryonic stem cells. Nat Genet., 37, 585-587.
70. Mitalipova, M.M., Rao, R.R., Hoyer D.M., Johnson, J.A., Meisner, L.F., Jones, K.L., Dalton, S., Stice, S.L. (2005). Preserving the genetic integrity of human embryonic stem cells. Nat Biotechnol., 23, 19-20.
71. Maitra, A., Arking, D.E., Shivapurkar, N., Ikeda, M., Stastny, V., Kassauei, K., Sui, G., Cutler, J., Liu, Y., Brimble, S.N., Noaksson, K., Hyllner, J., Schulz, T.C, Zeng, X., Freed, W.J., Crook, J., Abraham, S., Colman, A., Sartipy, P., Matsui S., Carpenter, M., Gazdar, A.F., Rao, M., Chakravarti, A. (2005). Genomic alterations in cultured human embryonic stem cells. Nat Genet., 37, 1099-1103.